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Naive pluripotency is manifest in the preimplantation
mammalian embryo. Here we determine transcrip-
tome dynamics of mouse development from the
eight-cell stage to postimplantation using lineage-
specific RNA sequencing. This method combines
high sensitivity and reporter-based fate assignment
to acquire the full spectrum of gene expression
from discrete embryonic cell types. We define
expression modules indicative of developmental
state and temporal regulatory patterns marking the
establishment and dissolution of naive pluripotency
in vivo. Analysis of embryonic stem cells and
diapaused embryos reveals near-complete conser-
vation of the core transcriptional circuitry operative
in the preimplantation epiblast. Comparison to inner
cell masses of marmoset primate blastocysts iden-
tifies a similar complement of pluripotency factors
but use of alternative signaling pathways. Embryo
culture experiments further indicate that marmoset
embryos utilize WNT signaling during early lineage
segregation, unlike rodents. These findings support
a conserved transcription factor foundation for naive
pluripotency while revealing species-specific regula-
tory features of lineage segregation.
INTRODUCTION
Pluripotency emerges in the mammalian epiblast during preim-
plantation blastocyst development. At the eight-cell stage, the
embryo undergoes compaction and outer cells are directed to-366 Developmental Cell 35, 366–382, November 9, 2015 ª2015 Theward the trophectoderm lineage. Interior cells become the inner
cell mass (ICM) and subsequently diverge into pluripotent
epiblast and extraembryonic primitive endoderm (PrE). In ro-
dents, the preimplantation epiblast state can be captured
in vitro as embryonic stem cells (ESCs) (Evans and Kaufman,
1981; Martin, 1981) and sustained indefinitely using defined
media (Buehr et al., 2008; Li et al., 2008; Ying et al., 2008). The
unrestricted potential of ESCs to generate all somatic tissues
and the germline is termed ‘‘naive’’ pluripotency, and differs
from other in vitro pluripotent states with respect to gene expres-
sion, signaling requirements, and epigenetic status (Brons et al.,
2007; Leitch et al., 2013; Marks et al., 2012; Nichols and Smith,
2009; Tesar et al., 2007).
Individual epiblast cells rapidly lose the ability to give rise to
self-renewing ESC colonies upon implantation (Boroviak et al.,
2014), evidencing the transient nature of naive identity in normal
development. The transition from the naive state is poorly char-
acterized in vivo and in vitro. Upon implantation, epiblast cells
acquire epithelial polarity (Bedzhov and Zernicka-Goetz, 2014)
and lose naive pluripotency marker expression entirely by em-
bryonic day (E)5.5 (Boroviak et al., 2014). However, the transcrip-
tional network associated with this progression has been ill
defined.
Pluripotency can be suspended in utero during diapause, a
facultative condition of embryonic arrest (Mantalenakis and
Ketchel, 1966; Mead, 1993; Renfree and Shaw, 2000). Embry-
onic diapause by delayed implantation has evolved to overcome
conditions unfavorable for reproduction (Ketchel et al., 1966;
Mantalenakis and Ketchel, 1966; Mead, 1993) and occurs in
over 100 mammalian species (Renfree and Shaw, 2000). The
distinction between transient, diapaused, and self-renewing
pluripotent states remains elusive (Nichols and Smith, 2012).
Human and nonhuman primate pluripotent cells are main-
tained in vitro with culture regimes distinct from those used
for mouse ESCs. They exhibit marked differences in geneAuthors
expression compared to primate preimplantation embryos
(Nakatsuji and Suemori, 2002; Thomson et al., 1996, 1998; Yan
et al., 2013). Propagation of nonhuman primate ESCs competent
for chimera contribution has proven elusive (Kishi et al., 2014;
Tachibana et al., 2012), although recent progress was reported
for rhesus macaque using altered culture conditions (Fang
et al., 2014). It is unclear why primate embryonic cells are
more refractory to authentic ESC derivation compared tomouse.
One contributing factor could be differences in signaling path-
ways driving lineage commitment and segregation in the ICM,
which have not been defined in the primate.
Advances in sequencing protocols have enabled quantitative
analysis of picogram amounts of RNA from individual cells and
facilitated the study of early mammalian development at unprec-
edented resolution (Guo et al., 2010; Kurimoto et al., 2006; Tang
et al., 2009). However, sequencing from minute quantities of
starting material compromises the detection of low-abundance
transcripts and impairs accurate estimation of expression levels
(Brennecke et al., 2013; Gru¨n et al., 2014). These limitations
reduce the potential for comprehensive molecular characteriza-
tion of individual cells. Here we show that this can be mitigated
by applying single-cell sample preparation methods to small
groups of cells. We adapted single-cell reverse-transcription
and preamplification (Tang et al., 2009) for compatibility with Illu-
mina sequencing and profiled clusters of 8–20 cells. This
approach yields substantial enhancement in transcript detection
and is suitable for experiments that call for accurate analysis of
small cell numbers without a requirement to measure cell-to-
cell variability.
We apply this technique to produce a transcriptional map of
early mouse development from morula to postimplantation
epiblast, and compare in vitro cultured ESCs and diapaused epi-
blasts in the context of this developmental sequence. We extend
this analysis to the common marmoset (Callithrix jacchus), a
small New World monkey presenting several practical advan-
tages as a model for primate embryology. Profiling transcrip-
tional activity in the inner cell mass of early-, mid-, and late-stage
marmoset blastocysts allows direct comparison of rodent and
primate development. These data reveal differences in regu-
latory timing and utilization of signaling pathways that we inves-
tigate through embryo culture experiments. Our results provide a
framework for delineating the emergence and developmental
progression of pluripotency in diverse mammals.
RESULTS
A Transcriptional Map of Early Mouse Development
We previously showed by qRT-PCR that a moderate increase in
starting material for whole-transcriptome amplification (Tang
et al., 2009) substantially increases signal fidelity and reproduc-
ibility (Boroviak et al., 2014). We extend this approach to RNA
sequencing (RNA-seq) to profile cell lineages from individual
mouse embryos. Four time points were analyzed from the
eight-cell stage at E2.5 to the early postimplantation epiblast at
E5.5 (Figure 1A; Table S1). Pdgfra::GFP knockin mice (Hamilton
et al., 2003; Plusa et al., 2008) enabled fluorescence-based sep-
aration of PrE from epiblast cells in E4.5 and E5.5 blastocysts.
We assessed transcript detection and expression-level esti-
mation relative to previously published single-cell (Xue et al.,Developm2013; Yan et al., 2013) and conventional RNA-seq data (Chan
et al., 2013; Marks et al., 2012). Transcription was measured
from up to 30% of annotated genes by single-cell RNA-seq,
consistent with previous reports (Brennecke et al., 2013; Gru¨n
et al., 2014). RNA-seq from 10–20 cells (8 in the case of E2.5
morulae) yielded detection rates of 60%–70%, comparable to
the performance of sequencing protocols frommicrogram quan-
tities of RNA (Figure 1B). Similar distribution profiles were
observed from bulk RNA and small numbers of cells, with
many genes expressed at low and intermediate levels and a
small proportion showing high expression (Figure 1C). In
contrast, single-cell data exhibit high expression-level estimates
for many genes and missing values for low-abundance tran-
scripts (Kharchenko et al., 2014). These results demonstrate
that profiling small cell clusters overcomes limitations in sensi-
tivity of single-cell analysis and allows quantification of gene
expression levels comparable to that of conventional transcrip-
tome sequencing.
Analysis of biological replicates spanning the five embryonic
stages produced discrete clusters, recapitulating their develop-
mental sequence (Figure S1A). Visualization by diffusion map, a
nonlinear dimensionality reduction method (Lafon et al., 2006),
shows that samples cluster primarily by stage, with the first co-
efficient capturing progression of development (Figure 1D). PrE
and preimplantation epiblast cells retain a high degree of similar-
ity despite the divergent developmental potential of the two line-
ages (Figure 1D; Figure S1A).
We examined pluripotency and lineage markers in more
detail. Our data confirm the sequential activation of PrE speci-
fiers previously described (Figure S1B) (Artus et al., 2011; Cha-
zaud et al., 2006; Gerbe et al., 2008; Guo et al., 2010; Kurimoto
et al., 2006; Ohnishi et al., 2014), whereas preimplantation
epiblast cells exhibited robust expression of exclusive markers
including Sox2, Nanog, Klf2, Bmp4, and Fgf4 (Guo et al., 2010;
Kurimoto et al., 2006; Tang et al., 2010a). Strikingly, however,
several transcription factors associated with pluripotency
were expressed in both lineages. Pou5f1 (Oct4) was expressed
at lower levels but was still present in PrE, consistent with
known protein distribution (Frum et al., 2013; Le Bin et al.,
2014; Palmieri et al., 1994). This pattern was evident for Klf4,
Dppa3, Nr0b1, Esrrb, and Zfp42 (Rex1). Klf5 and Tbx3 were ex-
pressed at higher levels in PrE (Figure 1E). This observation is
reflected in the cluster proximity of PrE and the preimplantation
epiblast (Figure 1D). These results illustrate that divergent
potency of related embryonic lineages can be conferred by a
small subset of regulatory factors in the context of a globally
similar transcriptome.
Defining Stage-Specific Gene Expression Modules in
Early Mouse Development
Lineage-specific profiling facilitated identification of gene sets
indicative of developmental state, lineage segregation, and pro-
gression. We defined dynamically expressed genes as those
transcribed differentially between at least two of the four embry-
onic stages analyzed and robustly detected in at least one
(fragments per kilobase of exon per million fragments mapped
[FPKM] > 10). The resultant set comprises 1,857 genes (Ta-
ble S2), and hierarchical clustering revealed ten expressionmod-
ules (Figure 2A; Figure S2A).ental Cell 35, 366–382, November 9, 2015 ª2015 The Authors 367
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Figure 1. Transcriptome Profiling of Mouse Embryonic Lineages
(A) Overview of the developmental sequence analyzed.
(B) Percentage of detected genes in RNA-seq data from single cells (white), small numbers of cells (blue), and conventional bulk RNA (black) on comparable cell
types (Xue et al., 2013; Yan et al., 2013, Marks et al., 2012).
(C) Distribution of nonzero expression values in log2 FPKM (fragments per kilobase of exon per million fragments mapped) for RNA-seq data from single cells
(white), small numbers of cells (blue), and conventional bulk RNA (black).
(D) Diffusion map of embryonic samples from morula to postimplantation epiblast; DC, diffusion coefficient.
(E) Marker expression delineates the divergence of epiblast and PrE lineages. Genes specific to PrE and the preimplantation epiblast are marked in green and
blue, respectively; shared genes are depicted in orange. Track width is scaled to relative expression normalized to the mean across all stages displayed.Genes maximally expressed in morulae included Tead4,
Sox15, Klf17, Nr5a2, and Tfap2c. Those common to morulae
and the ICM were Gata6, as well as trophectodermal markers
Hand1, Elf3, and Eomes. The latter group may underlie the ca-
pacity of early ICM cells to regenerate trophectoderm (Handy-
side, 1978; Nichols and Gardner, 1984; Rossant and Lis,
1979). Genes expressed throughout preimplantation develop-
ment but at varying levels included ESC markers Klf2, Klf4,
Klf5, Nr0b1, Zfp42, Prdm14, Tbx3, Tfcp2l1, and Esrrb. These
data provide a comprehensive set of transcription factors and
other genes downregulated upon implantation (Table S2).
In addition to Pou5f1 (Oct4) and Sall4, pluripotency markers
associated with both pre- and postimplantation epiblast include
Utf1, Foxd3, Zic3, and Fgf4. Tcf7l1 (Tcf3), a gene expressed in
embryonic stem cells and involved in pluripotency repression368 Developmental Cell 35, 366–382, November 9, 2015 ª2015 The(Martello et al., 2012; Wray et al., 2011; Yi et al., 2011), was up-
regulated at E4.5, potentially to prepare naive epiblast cells for
transition. Notably, 220 genes were specifically upregulated dur-
ing the preimplantation-to-postimplantation epiblast transition.
These include known regulators of early postimplantation devel-
opment, such as Pou3f1 (Oct6), Fgf5,Otx2, and Sox3, as well as
candidate regulators Tead2, Sall2, Mapk12, Fzd2, Rspo1, Smo,
and Notch3. We also observed strong upregulation of de novo
methyltransferases Dnmt3a and Dnmt3b, consistent with hypo-
methylation in naive pluripotent cells (Leitch et al., 2013; Smith
et al., 2012) and increased DNA methylation upon implantation
(Lee et al., 2014).
Genes expressed at high levels throughout the developmental
stages analyzed are listed in Table S3, and expression modules
specific to the epiblast versus PrE segregation process areAuthors
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provided in Figure S2B and Table S4. These results expand the
recent description of PrE-associated genes by single-cell micro-
array profiling (Ohnishi et al., 2014) and provide a resource to
identify regulators of PrE differentiation.
The initial progression from naive pluripotency in embryonic
development has not been well characterized. We analyzed
the E4.5-to-E5.5 transition before epiblast cells undergo line-
age priming in vivo and provide the complete set of differen-
tially expressed genes in Table S5. To examine the behavior
of an independent set of pluripotency-associated genes, we
used PluriNetWork, curated from published interaction data
(Som et al., 2010). Focusing on dynamically expressed genes
and the core regulators Pou5f1, Nanog, and Sox2, we reduced
the network to 82 nodes (PluriNet82; Figure 2B). Importantly,
the condensed network includes all validated regulators of
ESC pluripotency. Those downregulated during the E4.5-to-
E5.5 transition include naive markers Esrrb, Nr0b1, Klf2, Klf4,
Klf5 and Zfp42 (Rex1), as well as Lifr, Il6st (gp130), Spp1,
Tcl1, and Zfp57. Conversely, we observed upregulation of
Foxd3, Lef1, Ccnd1, Zscan10, Phc1, and Nr216 upon
implantation.
Visualization of temporal patterns shows robust expression of
naive markers during preimplantation development followed by
an abrupt shutdown and replacement with factors such as
Nodal, Lef1, and Fgf5, along with the activin receptor Acvr2b
(Figure 2C). Epigenetic modifiers associated with a permissive
chromatin state (Tet1, Tet2, Prdm14, Ncoa3) were predominant
during preimplantation development (Figure 2D). Upon implanta-
tion, these were exchanged for epigenetic regulators mediating
DNA methylation (Dnmt1, Dnmt3a, Dnm3b) and transition to
more closed chromatin configurations (Hdac5, Hdac11,
Suv39h1).
We integrated the RNA-seq data with 229 annotated Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways and
generated expressionmaps for pairwise comparison of develop-
mental stages (http://pathway-atlas.stemcells.cam.ac.uk). At
the preimplantation-to-postimplantation epiblast transition, we
noted differential expression of genes involved in tight junction
formation (Figure 1E). In particular, we detected upregulation
of Cldn6, important for epithelial formation (Turksen and Troy,
2001) and upregulated in mouse epiblast-derived stem cells (Te-
sar et al., 2007), and Cldn7 with Tjp1, essential for tight junction
establishment (Matter and Balda, 1999; Sleeman and Thiery,
2011). We also noted induction of Crb3 and Pard3, pivotal for
the establishment and maintenance of apical-basal polarity
(Shin et al., 2006). These results comprise a reference dataset
for regulatory network and pathway analysis during epiblast pro-
gression in vivo.Figure 2. Expression Modules Identified in Early Mouse Development
(A) Expression of dynamically expressed genes. Modules were derived by hiera
signaling pathway components, and epigenetic regulators are shown with plurip
(B) PluriNet82 at the transition from pre- to postimplantation stages. Label and n
preimplantation (E4.5; left) and postimplantation epiblasts (E5.5; right). Arrows in
(C) Genes characteristic of preimplantation (green) and early postimplantation de
mean across all stages displayed.
(D) Epigenetic modifiers expressed predominantly at preimplantation (green) or e
(E) Simplified representation of the KEGG ‘‘tight junction’’ pathway, with nodes co
epiblast (right).
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Assembled in the Preimplantation Epiblast
We sequenced RNA from ESCs cultured in 2i/LIF (leukemia
inhibitory factor) without feeders or serum (Ying et al., 2008), pro-
cessed identically to embryonic samples to allow direct compar-
ison. Global analysis showed tight correlation between biological
replicates and confirmed the shared identity of ESCs and the
preimplantation epiblast (Figures S3A and S3B). Restricting the
comparison to dynamically expressed genes reveals concor-
dance in the developmental state, with ESCs displaying a
near-identical profile to the E4.5 epiblast (Figure 3A; Figure S3C).
Consistent with this, genes differentially expressed between
ESCs and embryonic cells were fewest for the E4.5 epiblast, indi-
cating the greatest correspondence with emergent pluripotent
cells in the blastocyst (Figure 3B). Pathway enrichment analyses
showed most changes in ESCs to be associated with meta-
bolism, potentially rooted in the biophysical environment and
nutrient utilization (Figure 3C).
We examined the behavior of regulatory networks governing
pluripotency in ESCs in the context of in vivo development. To
capture changes over time, we computed normalized expres-
sion relative to the mean level of each gene across all develop-
mental stages and defined genes with positive values as
preferentially active at a given stage. Mapping these values to
PluriNet82 reveals changes in network topology during early
mouse development (Figure 3D). Few pluripotency genes ex-
hibited robust expression at the morula stage, with substantially
more upregulated in the early ICM. Most peaked at the preim-
plantation epiblast stage, resulting in maximum interconnectiv-
ity. This was abolished following implantation, marking the
dissolution of naive pluripotency in vivo.
We proposed a reduced set of abstract Boolean network
models for ESC self-renewal comprising 11 transcription factors
and the extracellular signal-regulated kinase (Erk)/mitogen-acti-
vated protein (MAP) kinase (Dunn et al., 2014). To relate this to
the embryo, we asked whether a developmental stage can be
identified at which all components are present. Intersecting
data from morula, early ICM, and pre- and postimplantation
epiblast cells revealed that the only time point at which these
regulators were coexpressed was the preimplantation epiblast
(Figure 3E). Thus, transcriptional regulation in cultured ESCs cor-
relates specifically with the naive phase of pluripotency in the
embryo.
Diapaused Epiblasts Maintain All Features of Naive
Pluripotency
Rodents have evolved the capacity for facultative developmental
arrest at the late blastocyst stage (Mantalenakis and Ketchel,and the Preimplantation-to-Postimplantation Epiblast Transition
rchical clustering of scaled expression values. Selected transcription factors,
otency-associated genes in bold.
ode sizes reflect interaction number. Colors represent expression in FPKM for
dicate positive interactions; T bars indicate inhibitions.
velopment (red). Track width is scaled to relative expression normalized to the
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Figure 3. ESCs Retain Expression Modules Defining the Preimplantation Epiblast
(A) Diffusion map from morula to postimplantation epiblast and ESC cultured in 2i/LIF, based on dynamically expressed genes.
(B) Genes differentially expressed (p < 0.05) between ESCs and embryonic samples.
(C) Most significantly enriched GO and KEGG pathways based on up- and downregulated genes in ESC versus preimplantation epiblast.
(D) Changes in expression of PluriNet82 genes in the embryonic lineage. A node is displayed if the corresponding gene is predominantly active at that devel-
opmental stage, defined as positive log-transformed expression relative to the mean across all stages. An edge is displayed if both source and target nodes are
active.
(E) Minimal set of transcription factors operative in mouse ESCs (Dunn et al., 2014). Colors represent gene expression in FPKM. Expression levels are depicted for
morula, early ICM, and pre- and postimplantation epiblasts clockwise from the top left.1966;Mead, 1993; Renfree and Shaw, 2000). ESCswere first ob-
tained from embryos in diapause (Evans and Kaufman, 1981),
and the condition is known to facilitate ESC derivation (Brook
and Gardner, 1997). We induced implantation delay by ovariec-
tomy (Weitlauf and Greenwald, 1968) and isolated diapausedDevelopmepiblasts for RNA-seq as above. Diapaused embryos vary from
those undergoing normal development (Figure 4A) and cluster
separately by correlation analysis (Figure S4A). To characterize
these differences, we examined Gene Ontology (GO) term
enrichment for differentially expressed genes (Figure S4B). Inental Cell 35, 366–382, November 9, 2015 ª2015 The Authors 371
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Figure 4. Relationship between Diapaused Epiblast, Normal Embryonic Development, and ESC
(A) Diffusion map of developmental stages from morula to postimplantation epiblast, ESC, and diapaused epiblast.
(B) Expression scores for selected signaling pathways, scaled to the mean across the three cell types, calculated by summing FPKM values of individual
components followed by normalization for pathway size.
(legend continued on next page)
372 Developmental Cell 35, 366–382, November 9, 2015 ª2015 The Authors
diapause, the most significant downregulated processes relate
to metabolism, cell cycle, and biosynthesis. Conversely, those
upregulated include negative regulation of metabolism and
biosynthetic processes. Apart fromperoxisome proliferator-acti-
vated receptor (PPAR) signaling, pathway expression scores
were generally reduced in diapaused epiblasts and particularly
components of the mechanistic target of rapamycin (mTOR)
pathway (Figure 4B). These features likely reflect a general state
of dormancy in diapaused embryos.
We found all pluripotency factors to be expressed in the
diapaused epiblast, indicating retention of naive identity (Fig-
ure S4C). It has been shown that Lifr and Il6st serve an essen-
tial function in epiblast maintenance during diapause (Nichols
et al., 2001), implicating the Janus kinase (JAK)/signal trans-
ducer and activator of transcription (STAT) pathway in sustain-
ing pluripotency. Analysis of JAK/STAT components revealed
that receptors, signal transducers, and downstream targets
are robustly expressed in normal preimplantation development,
ESCs, and diapaused epiblasts but are not maintained postim-
plantation (Figure 4C). Pluripotency factor targets of Stat3, Klf4,
and Tfcp2l1 (Bourillot et al., 2009; Hall et al., 2009; Martello
et al., 2013; Niwa et al., 2009; Ye et al., 2013) were expressed
at high levels in diapause. We also observed substantial upre-
gulation of Wnt4, concomitant with high expression of the WNT
targets Esrrb (Martello et al., 2012), Axin2 (Lustig et al., 2002),
and Cdx1 (Pilon et al., 2007) (Figure 4C; Figure S4C). Wnt
expression in normal development was mainly confined to the
early ICM (Wnt6, Wnt7b), with low levels of Wnt4 present in
all stages analyzed. Thus, WNT signaling may play a specific
role in extended maintenance of the pluripotency network dur-
ing diapause.
We assessed genome-wide differences in expression of tran-
scription factors and epigenetic regulators between the preim-
plantation epiblast, diapause, and ESC (Figure 4D). Few factors
were highly expressed in only one condition and most were pre-
sent in at least two, in particular ESC and preimplantation
epiblast or ESC and diapause. Expression modules including
all genes for preimplantation epiblast, diapause, and ESC
appear in Table S4. ESC-specific transcripts include Phgdh
and Aldoa, involved in glycolysis and L-serine biosynthesis,
respectively (Figure 4E). Piwil4, a repressor of transposable ele-
ments, and Sod3, a superoxide dismutase, may act to maintain
genomic integrity during diapause. Genes highly upregulated in
both diapause and ESC included Socs3, a JAK/STAT down-
stream target, and Stard4, encoding a putative lipid transfer pro-
tein.We examined the relationship of diapaused epiblasts to em-
bryo samples and ESCs based on all 1,857 genes dynamically
expressed during normal development. Remarkably, diapause
samples were placed directly adjacent to the preimplantation
epiblast and ESC in the diffusion map (Figure 4F). These results
show self-renewing ESCs and diapaused embryos to embody an
arrested state of the transient E4.5 epiblast that retains develop-
mental identity, despite substantial changes in environment in(C) Selected components of WNT and JAK/STAT signaling pathways for the sam
(D) Ternary plot of the most divergent transcriptional and epigenetic regulators bet
scaled to the mean across the three cell types and are log transformed.
(E) Differentially expressed genes in FPKM between preimplantation epiblast, dia
(F) Diffusion map based on dynamically expressed genes from morula to postim
Developmthe case of ESCs and profound changes in metabolism, prolifer-
ation, and biosynthetic activity in diapause.
Direct Comparison of Rodent and Primate ICM
Preimplantation embryogenesis in primates is protracted relative
to rodents, and detailed molecular and functional characteriza-
tions are lacking. Protocols for minimally invasive embryo recov-
ery have been developed for marmoset, providing access to
embryos that have undergone normal gestation in utero (Thom-
son et al., 1994; Hanazawa et al., 2012), a resource that is not
accessible from humans. We therefore utilized the common
marmoset to investigate the transcriptional makeup of primate
ICM in comparison to early mouse development.
Marmoset embryos were collected by nonsurgical uterine
flush. The ICMs of early-, mid-, and late-stage blastocysts
were isolated by immunosurgery (Figures S5A–S5C) and profiled
by RNA-seq (Table S6). Marmoset ICMs were processed whole
due to lack of reporter systems in the primate. Mixed expression
of epiblast and PrE markers is therefore expected from late ICM
(Figures 5C and 5D). Samples clustered largely by develop-
mental stage (Figure S5H). Substantial differences between
species were apparent (Figure 5B), embodied primarily in the
first diffusion coefficient. The second coefficient appears to
reflect progression of development in both mammals.
Expression of many pluripotency factors, including Pou5f1,
Sox2, Nanog, Esrrb, Klf4, Tbx3, and Tdgf1, was conserved be-
tween species (Figure 5C). However, we noted changes in Pluri-
Net82 connectivity imparted by the absence of KLF2, FBXO15,
NR0B1, and GBX2 in marmoset (Figure 2B). Two of these, Klf2
and Gbx2, are proposed core naive pluripotency regulators in
mouse ESCs (Figure 3E). We then assessed localization of naive
pluripotency factors by immunofluorescence at the early-mid
blastocyst stage. KLF4 and TFCP2L1 were predominantly ex-
pressed in the ICM and largely correlated with NANOG, albeit
with slightly broader distribution (Figures 5D and 5E). These fac-
tors are thus coexpressed in a subset of ICM cells in the
marmoset blastocyst, as also observed in human (Takashima
et al., 2014). Intriguingly, E-CADHERIN staining was intense in
the trophectoderm but diffuse in the ICM (Figure 5E).
Distinctions evident from the wider pluripotency network
prompted us to investigate potential differences in epiblast and
PrE specification in primate ICM. In mouse, sequential activation
of early PrE markers (Gata6, Pdgfra) is followed by upregulation
of late markers (Gata4, Foxa2) upon lineage segregation (Fig-
ure 5F). The majority of key PrE regulators, including GATA6,
SOX17, and GATA4, were also present at high abundance in
marmoset ICM. We performed further immunostaining for
GATA4 andGATA6 to assess specificity to PrE. Initially, NANOG
and GATA6 were coexpressed in the early ICM (Figure 5G),
similar to mouse (Plusa et al., 2008; Schrode et al., 2014) and hu-
man (Roode et al., 2012). At the mid-blastocyst stage, we
observed mutually exclusive staining of NANOG and SOX17
(Figure 5H). KLF4 was expressed at low levels throughout theples indicated.
ween preimplantation epiblast, ESC, and diapaused epiblast. FPKM values are
paused epiblast, and ESC, as indicated.
plantation epiblast, ESC, and diapaused epiblast.
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embryo, but with stronger signal in NANOG-positive cells of the
ICM (Figure 5H). OCT4 tightly colocalized with NANOG in the
presumptive epiblast of late blastocysts (Figure 5I). In contrast,
GATA4 and OCT4 staining were mutually exclusive in the ICM,
with GATA4 specific to PrE and OCT4 confined to the epiblast
(Figure 5J). Confocal microscopy of late marmoset blastocysts
revealed that GATA6-positive cells formed a distinct layer over-
lying NANOG-positive cells within the ICM, indicating restriction
of GATA6 to PrE (Figure 5K). We conclude that mouse and
marmoset share the majority of PrE specifiers.
FGF and WNT Signaling Are Required for Lineage
Segregation in the Marmoset Blastocyst
To further relate mouse and marmoset embryos, we combined
data from E4.5 epiblast and PrE mouse samples to allow com-
parison to the late marmoset ICM (Figure S5J; Table S7). Hierar-
chical clustering of an independent panel of genes selected by
the International Stem Cell Initiative (Adewumi et al., 2007)
revealed broad conservation in expression patterns of many plu-
ripotency and lineage markers but differences in signaling
pathway components, including Lifr, Fgf4, and Nodal (Fig-
ure S5J). Knowledge of pathways regulating PrE segregation
and epiblast specification in primates is limited. We focused on
the regulation of pathway components at the early ICM stage,
whenNANOG andGATA6 are coexpressed (Figure 5G) and indi-
vidual cells are indistinguishable at the transcriptome level in
mouse (Ohnishi et al., 2014). The most significant differentially
expressed pathways in marmoset included ascorbate and aldo-
rate, inositol phosphate and lipoic acid metabolism, lysine
biosynthesis, and PPAR signaling (Figure S5I). Pathways upre-
gulated in mouse included arginine and proline metabolism
and proteasome, estrogen receptor, andmTOR signaling. These
results highlight metabolic differences, in particular with regard
to amino acid biosynthesis, between the mouse and marmoset
embryo.
We then examined signaling pathways by combining gene
expression with KEGG pathway maps. We observed pro-
nounced differences in major cascades such as transforming
growth factor b (TGF-b), fibroblast growth factor (FGF), and
WNT (Figures 6A–6C; Figure S6). Marmoset early ICM cells ex-
pressed high levels of ACVR1B (ALK4), TGFBR1 (ALK5), and
ACVR2A (Figure 6A; Figure S6A). Interestingly, BMP4 is not de-
tected in marmoset (Figure S6D), but NODAL is expressed from
the early blastocyst stage (Figure 6A; Figure S6A). FGF4 is
absent in the early ICM and is upregulated at later stages. Addi-
tionally, we noted altered levels of FGF receptor expression (Fig-
ure 6C; Figure S6C). In relation to WNT signaling, the secreted
Wnt inhibitor DKK1 and the negative regulator of b-catenin
GSK3b were highly upregulated, which together with reduced
b-catenin (CTNNB1) (Figure 6B; Figure S6B) may indicate sup-Figure 5. Pluripotency Factors Are Conserved, whereas Signaling Rec
(A) Staging criteria for isolation of early, mid, and late marmoset ICM and images
(B) Diffusion map of mouse and marmoset embryonic samples.
(C) Pluripotency gene expression for mouse and marmoset embryonic samples.
(D and E) Confocal z projections of whole-mount marmoset early-mid blastocys
(F) PrE-associated gene expression for mouse and marmoset embryonic sample
(G–J) Immunofluorescence stainings of early, mid (H), and late marmoset blastoc
(K) z-x cross-section of marmoset blastocyst stained for the markers indicated.
Developmpression of WNT signaling in the early primate ICM. At the late
blastocyst stage, however, DKK1 diminished, concomitant
with an increase in CDX1. This suggests the possibility of a spe-
cific role for the WNT pathway in the marmoset blastocyst. Thus,
although transcription factor expression is largely conserved
between the rodent and primate embryo stages examined, the
repertoire of signaling pathway components differs.
To investigate the functional relevance of these expression
patterns, marmoset morulae were cultured to the late blastocyst
stage in the presence of selective pathway inhibitors (Figure 6D).
Embryos were subsequently immunostained for NANOG,
GATA6, and CDX2. Cell number and fluorescence intensities
were measured with automated analysis software (Volocity; Per-
kinElmer) (Figure 6E, left column; Figures S7A–S7F). Mouse em-
bryos were cultured and analyzed under identical conditions for
direct comparison. Inhibitor treatment did not affect total cell
number (Figure S7G). In marmoset DMSO-treated controls, the
epiblast and PrE had segregated in late blastocysts, as indicated
by mutually exclusive NANOG (NANOG-only) and GATA6
(GATA6-only) staining in subsets of inner cells (Figure 6D, arrow-
heads). GATA6 was also expressed in the trophectoderm, but at
lower levels and in combination with CDX2 (Figures S7G and
S7H). The ratio of epiblast (NANOG-only) to PrE (GATA6-only)
cells was higher in marmoset embryos compared to mouse
(Figure 6E).
In mouse embryos, inhibition of FGF signaling ablated PrE for-
mation and increased the epiblast compartment (Figure 6E),
whereas inhibition of WNT and TGF-b/Nodal signaling did not
elicit significant effects, consistent with previous reports (Bie-
chele et al., 2013; Nichols et al., 2009; Yamanaka et al., 2010).
In marmoset, blocking the type I TGF-b/activin/Nodal receptor
with A8301 did not disrupt lineage segregation (arrowheads for
GATA6-only cells in Figure 6D). However, inhibition of ERK or
WNT signaling led to coexpression patterns rarely observed in
control embryos (Figure 6E; Figure S7H). NANOG-only cells in
marmoset embryos increased upon ERK pathway inhibition (Fig-
ures 6D–6F). WNT signaling inhibition led to strong upregulation
of NANOG, GATA6, and CDX2, and in particular the number of
NANOG-high cells was substantially greater (Figures 6D, 6E,
and 6G). Strikingly, emergence of GATA6-only PrE cells was
suppressed by both ERK and WNT signaling inhibition (Fig-
ure 6H; Figure S7I).
We assessed whether the observed effects of TGF-b, WNT,
and ERK inhibition might be combined by carrying out dual-inhi-
bition experiments (Figure 7A). Conditions including WNT inhibi-
tion led to greater proportions of NANOG-only cells (Figure 7B),
with a substantial increase in NANOG-high cells (Figure 7C). PrE
formation was impaired in all dual-inhibition experiments (Fig-
ures 7A and 7D). The most profound reduction occurred when
both WNT and ERK signaling were inhibited (Figure 7D),eptors Diverge, in Mouse and Marmoset ICM
of the blastocysts analyzed.
Error bars represent SD.
t immunofluorescence stainings for the markers indicated.
s. Error bars represent SD.
yst.
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indicating an additive effect. These results support a conserved
role for FGF/ERK signaling and a marmoset-specific function for
WNT signaling in ICM lineage segregation (Figure 7E).
DISCUSSION
In this study, we applied single-cell RNA-seq protocols to clus-
ters of cells to determine genome-wide transcriptional activity
in developing embryonic lineages. This analysis defined stage-
specific gene expression modules of lineage identity and fate
specification. Furthermore, our data establish that mouse
ESCs and diapaused epiblasts sustain preimplantation epiblast
identity despite major environmental or metabolic changes. We
found the regulatory network governing naive pluripotency in
ESCs to be progressively activated in the embryo and maximally
around E4.5. Heterogeneous ICM cellsmay individually progress
to this stage over the preceding 12–18 hr. Indeed, from E3.75 on-
ward, ESCs can be derived from single ICM cells in stringent
2i/LIF culture (Boroviak et al., 2014).
The gene expression module of the pre- and postimplantation
epiblast contains drivers that act to dismantle the naive pluripo-
tency circuitry. Prominent examples include Fgf4, an activator of
Erk signaling and subsequent differentiation (Kunath et al.,
2007), and Tcf7l1 (Tcf3), a repressor of naive pluripotency (Mar-
tello et al., 2012; Wray et al., 2011; Yi et al., 2008). Consequently,
naive pluripotency factors are abruptly eliminated upon implan-
tation. These data are inconsistent with the proposition that
pluripotency is an inherently precarious balance, wherein plurip-
otency factors act continuously as competing lineage specifiers
(Loh and Lim, 2011). Restriction to preimplantation development
precludes these factors from playing a role in lineage specifica-
tion. We propose that pluripotency is not intrinsically poised for
differentiation but progresses through at least three phases:
naive, formative, and primed (Kalkan and Smith, 2014). Line-
age-specific profiling of the E5.5 epiblast is expected to capture
the fundamental attributes of the formative phase.
We uncovered parallels in signaling activity between ESC and
diapause. Stabilization of b-catenin via GSK3 inhibition is impor-
tant for maintenance of naive pluripotency in mouse ESCs (Wray
et al., 2011; Ying et al., 2008). Abrogation of Tcf7l1 function by
b-catenin results in stable expression of the key pluripotency
factors Esrrb, Klf2, and Nanog (Martello et al., 2012; Wray
et al., 2011). This effect of GSK3 inhibition can be partially repro-
duced by WNT, and together with either LIF stimulation or
MAPK/ERK kinase (MEK) inhibition allows continuous propaga-
tion of mouse ESCs (Dunn et al., 2014; ten Berge et al., 2011;
Wray et al., 2011; Ying et al., 2008). In diapaused epiblasts, we
identified high levels of the Jak/Stat downstream targets Klf4
and Tfcp2l1 (Bourillot et al., 2009; Martello et al., 2013) and
expression of Lifr and Il6st (gp130), reflecting the essential roleFigure 6. FGF and WNT Inhibition Disrupt Lineage Segregation in the M
(A–C) Expression of selected components of the TGF-b/NODAL, FGF, and WNT
(D) Confocal z projections of inhibitor-treated marmoset late blastocysts stained
(E) Fluorescence signal from cells labeled for lineage markers in mouse and ma
blastocyst stage in the presence of A8301 (3 mM), PD0325901 (3 mM), IWP2 (3 m
(F–H) Quantification of (F) NANOG-only, (G) NANOG-high, and (H) GATA6-only c
bars at minimum and maximum values. Outliers are indicated with a cross. NANO
values were computed by one-way ANOVA with Tukey HSD (honest significant d
Developmof LIF signaling in diapause (Nichols et al., 2001). We also
observed strongWnt4 and Axin2 expression in diapause, poten-
tially indicative of WNT signaling activity. Because Tcf7l1 is ex-
pressed during diapause, WNT signaling may be important for
sustaining naive pluripotency in the dormant epiblast. We spec-
ulate that pathways evolved to mediate developmental arrest
in vivo may facilitate in vitro capture of the naive state (Nichols
et al., 2001; Nichols and Smith, 2012).
In primate embryos, we found the majority of pluripotency-
associated genes to be expressed in the ICM. However,
absence of KLF2, NR0B1, FBXO15, and BMP4 suggests ad-
aptations in the wider pluripotency network. Similar patterns
are observed in human embryos (Blakeley et al., 2015; Yan
et al., 2013), lending support for a high degree of conservation
of core regulatory interactions in primates. Indeed, the major-
ity of human epiblast-specific factors including KLF17,
LEFTY1, and NODAL (Blakeley et al., 2015) are also ex-
pressed in the late marmoset ICM. These data confirm simi-
larities between human and marmoset, and highlight the rele-
vance of tractable nonhuman primate species as a model for
early development.
Transcriptional data revealed dissimilar expression of FGF,
WNT, and TGF-b/Nodal pathway genes. In human, there are
conflicting reports regarding the role of TGF-b/Nodal signaling
in the embryo (Blakeley et al., 2015; Van der Jeught et al.,
2014). We show that NANOG expression in the marmoset ICM
does not require FGF, WNT, and TGF-b/Nodal signaling. In
particular, we noted an increase in NANOG-positive cells when
ERK activation is inhibited by PD03. Robust expression ofNanog
in the absence of FGF/ERK signaling is reported in a variety of
species, including mouse, rat, bovine, and human blastocysts
(Kuijk et al., 2012; Nichols et al., 2009; Roode et al., 2012), and
may present a general feature of naive pluripotency in mammals.
Recent advances in the generation of naive pluripotent human
ESCs (Takashima et al., 2014; Theunissen et al., 2014) provide
support for this hypothesis.
Suppression of MEK via PD03 blocks PrE formation in rodent
embryos (Arman et al., 1998; Kuijk et al., 2012; Nichols et al.,
2009; Ralston and Rossant, 2005; Roode et al., 2012;
Yamanaka et al., 2010). This effect seems to be attenuated in
human (Kuijk et al., 2012; Roode et al., 2012), suggesting
involvement of additional mechanisms. We found that WNT inhi-
bition increased NANOG, GATA6, and CDX2 in marmoset
embryos, leading to a blurring of lineage boundaries. Cells failing
to undergo lineage specification may remain trapped at an
earlier developmental stage when NANOG and GATA6 are
coexpressed. Interference with ERK signaling reduced the num-
ber of PrE cells and broadened expression of CDX2 andNANOG.
We propose that lineage specification in primate preimplantation
development is regulated by both WNT and FGF/ERK pathways,armoset Blastocyst
signaling pathways.
for NANOG, CDX2, GATA6, and DAPI.
rmoset embryos. Morulae were cultured under identical conditions to the late
M), or DMSO (control) for 3 and 4 days in mouse and marmoset, respectively.
ells. Plotted are the first and second quartiles of data points (boxed) with error
G-high cells displayed at least 1.53 average NANOG fluorescence intensity. p
ifference) testing.
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Figure 7. Dual FGF and WNT Inhibition
Increases NANOG Levels and Blocks PrE
Formation
(A) Confocal z projections of inhibitor-treated
marmoset late blastocysts stained for NANOG,
CDX2, GATA6, and DAPI.
(B–D) Fluorescence quantification of (B) NANOG-
only, (C) NANOG-high, and (D) GATA6-only cells.
Outliers are indicated with a cross. NANOG-high
cells displayed at least 1.53 average NANOG
fluorescence intensity. p valueswere computed by
one-way ANOVA with Tukey HSD testing.
(E) Model of pathways driving lineage specification
in mouse and marmoset ICM.
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in contrast to mouse, where FGF/ERK is the primary and suffi-
cient driver (Figure 7E).
This study provides a comprehensive resource for identifying
the factors and pathways that ignite and extinguish naive plurip-
otency in vivo. Knowledge gained should be valuable for evalu-
ating and optimizing ESC differentiation and reprogramming to
pluripotency in vitro. A further application may be to influence
lineage decisions in embryo culture in order to facilitate stem
cell derivation or even to improve human blastocyst develop-
ment for assisted conception.
EXPERIMENTAL PROCEDURES
Mouse Strains and Embryo Collection
Mice used were intercrosses of Pdgfra::GFP (Hamilton et al., 2003) and strain
129 estrus-checked females. Embryos were collected at the relevant stages
from the oviduct or uterus in M2 medium (Sigma). Embryonic diapause was
induced by surgical removal of both ovaries on the morning of the third day
of pregnancy (E2.5). Diapaused embryos were flushed on the seventh day of
pregnancy. Experiments were performed in accordance with EU guidelines
for the care and use of laboratory animals, and under authority of UK govern-
mental legislation. Use of animals in this project was approved by the ethical
review committee for the University of Cambridge, and relevant Home Office
licenses are in place.
Marmoset Colony Maintenance and Embryo Collection
Primate embryos were obtained from the German Primate Center, Go¨ttingen
(Deutsches Primatenzentrum; DPZ) and the Central Institute for Experimental
Animals, Kanagawa, Japan (CIEA). Marmoset blastocysts were retrieved by
nonsurgical uterine flush according to established methods using recently
developed devices (Takahashi et al., 2014; Thomson et al., 1994). Because
the time of conception must be determined retrospectively and with an accu-
racy of ±24 hr, we applied additional criteria to embryo staging such as blas-
tocoel formation and diameter (Figure 5A). Staging of female reproductive
cycles and protocols for embryo retrieval have been described (Hanazawa
et al., 2012). Animals were obtained from self-sustaining colonies and housed
according to standard husbandry guidelines. Protocols for the use of animals
and institutional regulations for the care and experimental use of marmosets
were strictly followed. Experiments at the DPZ were conducted under license
number AZ 33.42502–066/06. Experiments using marmosets at the CIEA were
approved by the animal research committee (CIEA 11028) and performed in
compliance with guidelines set forth by the Science Council of Japan.
Isolation of Single-Cell Suspensions
Mouse (E3.25–E4.5) andmarmoset blastocysts were subjected to immunosur-
gery as previously described (Nichols et al., 1998; Solter and Knowles, 1975).
ICMs were subsequently dissociated from residual trophectoderm with a
narrowly fitting Pasteur pipette. For postimplantation mouse embryos, the
epiblast was isolated by manual dissection. Dissociation of morulae, ICM,
and postimplantation epiblast was carried out in a mixture of trypsin and chick
serum (see Supplemental Experimental Procedures). Cells were dissociated
by repetitive pipetting using blunted microcapillaries.
Embryonic Stem Cell Culture
E14TG2a cells derived from mouse strain 129/Ola (Hooper et al., 1987) were
used as a reference ESC line and cultured in 2i/LIF conditions (Ying et al.,
2008). N2B27 (1:1 DMEM/F-12 and Neurobasal media, N2 [in-house] and
B27 [GIBCO] additives, 2 mM L-glutamine, and 100 mM b-mercaptoethanol)
was supplemented with 1 mM PD0325901, 3 mM CHIR99021, and 10 ng/ml
LIF (in-house), and cells were maintained in gelatin-coated (0.1%) culture ves-
sels. Cells were dissociated by conventional methods, and 20 cells per sample
were manually selected with a blunt microcapillary.
Transcriptome Analysis
Library construction was carried out using whole-transcriptome preamplifica-
tion (Tang et al., 2009, 2010b) followed by sonication of cDNA and preparationDevelopmof Illumina-compatible sequencing constructs (see Supplemental Experi-
mental Procedures). Sequencing reads were processed to remove preamplifi-
cation adapters and were aligned with GSNAP (Wu and Nacu, 2010). Global
analyses were based on variance-stabilized counts computed with the Bio-
conductor package DESeq (Anders and Huber, 2010). Differential expression
analysis was performed in DESeq. Gene clusters were identified by hierarchi-
cal clustering on scaled FPKMs. The GOstats R package (Falcon and Gentle-
man, 2007) was used for GO category and KEGG pathway enrichment
analysis. High-level comparative analysis of KEGG pathways was based on
themean expression of constituent genes. For analysis of individual pathways,
expression values weremapped onto pathway nodes using PathVisio (Kutmon
et al., 2015). PluriNet82 was created by intersecting PluriNetWork (Som et al.,
2010) with dynamically expressed genes. Preferential activity at a given em-
bryonic stage was defined as positive-scaled log-normalized expression for
a network node; a network edge was required to have active source and target
nodes. Cytoscape (Smoot et al., 2011) was used for network visualization.
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